Reinforces Trinity Biotech’s growing position as a key player in diabetes care innovation– Senior commercial executives of Trinity Biotech are ...

Doctors warn that heavy reliance on HbA1c for diabetes diagnosis in India may lead to under- or over-diagnosis due to high anaemia and kidney disease burden, urging multiparametric testing ...

New patent points to HbA1c estimation, providing blood glucose trends and not real-time feedback ...

A Lancet Regional Health study warns that HbA1c, India's most used diabetes test, may misdiagnose or delay detection due to ...

A new evidence-based viewpoint published online in Lancet Regional Health: Southeast Asia highlights that the widely used ...

Researchers are cautioning against relying solely on glycated haemoglobin (HbA1c) for diagnosing and monitoring diabetes in South Asia, especially India, due to the high prevalence of anaemia and ...

Researchers are cautioning against relying solely on glycated haemoglobin, ‘HbA1c’, for diagnosing and monitoring diabetes in ...

Most people assume diabetes is easy to diagnose. You take a blood test, get a number, and that’s it. But in real life, it’s ...

Experts warn that relying solely on HbA1c for diagnosing type-2 diabetes in India may lead to misleading results.

Co-author Dr. Shashank Joshi from Mumbai highlighted that even in advanced urban hospitals, HbA1c results can be influenced by red blood cell variations. In rural and tribal regions, where anemia and ...

A Lancet study warns that the common HbA1c diabetes test may be unreliable for millions of Indians due to high rates of ...

Reinforces Trinity Biotech’s growing position as a key player in diabetes care innovation – Senior commercial executives of Trinity Biotech are attending the World Health Expo from February 10-12, ...